C2-dihydroceramide,
dihydro-ceramide,
dihydroceramide,
N-acetylsphinganine,
C2 Dihydroceramide,
C2-dihydroceramide,
N-acetylsphinganine,
N-acetyldihydrosphingosine,
N-Acetyl dihydrosphingosine,
13031-64-6,
UNII-ZZK8X1CR0R,
dihydro-C2-ceramide,
ZZK8X1CR0R,
N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]acetamide,
CHEBI:64913,
D-erythro-Sphingosine, Dihydro-, N-Acetyl-,
dS-N-Acetylsphinganine,
D-erythro-N-Acetylsphinganine,
C2 Sphinganine,
TIC-016,
N-Acetyl dihydrosphingosine [INCI],
C2 dihydrosphingosine,
N-02:0 Sphinganine,
D-erythro-2-Acetamido-1,3-octadecanediol,
N-(acetoyl)-sphinganine,
D-erythro-1,3-Dihydroxy-2-acetamidooctadecane,
CBiol_002032,
BSPBio_001567,
KBioGR_000287,
KBioSS_000287,
AC1O7M12,
BML3-C11,
CHEMBL155886,
SCHEMBL1479036,
N-acetoyl-D-erythro-sphinganine,
CTK6D9408,
KBio2_000287,
KBio2_002855,
KBio2_005423,
KBio3_000573,
KBio3_000574,
DTXSID20156452,
CRJGESKKUOMBCT-VQTJNVASSA-N,
Bio1_000318,
Bio1_000807,
Bio1_001296,
Bio2_000287,
Bio2_000767,
HMS1361O09,
HMS1791O09,
HMS1989O09,
HMS3402O09,
Acetamide, N-((1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl)-,
ZINC8860494,
Acetamide, N-(2-hydroxy-1-(hydroxymethyl)heptadecyl)-, d-erythro-,
C2 Dihydroceramide (d18:0/2:0),
Acetamide, N-(2-hydroxy-1-(hydroxymethyl)heptadecyl)-, (R-(R*,S*))-,
CCG-208049,
IDI1_034037,
NCGC00161358-01,
NCGC00161358-02,
NCGC00161358-03,
(2S,3R)-2-acetylaminooctadecane-1,3-diol,
Dihydroceramide C2, >=98% (TLC), solid,
FT-0664466,
J-005790,
BRD-K62910157-001-01-9,
C2 Dihydroceramide (d18:0/2:0), N-acetoyl-D-erythro-sphinganine, powder,
ceramide,
Dihydroceramide,
dihydro-ceramide,
CID6610273,
D03419,
C109343,